Player is loading...

Embed

Copy embed code

Transcriptions

Note: this content has been automatically generated.
00:00:00
the audience you are still sitting but always reinvented stan i'm expecting really allow
00:00:06
normalisation with regards to rehabilitation of patients are we gonna show you why
00:00:14
the problem is in the uh neural degenerative diseases
00:00:19
uh it to be important to have a really early therapy which starts immediately for example of the stroke
00:00:25
so we have at the moment the sitting ball uh we have some robotic
00:00:30
uh therapies which simulate the horse or yeah for example horse itself
00:00:35
so in general they're quite on safe uh really expensive and time consuming to
00:00:40
perform drunk therapy to improve your just a tack strengthening and your muscles
00:00:46
that's why we invented sitting with a mobile suits to mow belies the power base and
00:00:53
the back muscles it's quite efficient it's game oriented
00:00:57
we will perform an independent a therapy as well of the patient itself
00:01:02
and it is also a adjustable two different kind of levels of the page
00:01:09
but all this is already on the market with your fixture we you
00:01:12
have to patent there are two hundred fifty chairs of them sort
00:01:16
there is a certain torn over at the moment but we want to go into medical technology with that
00:01:22
the knowledge itself has a prototype to already realised we when
00:01:26
we perform the study with with that twelve patients
00:01:30
having already some software is developed and a t. c. capital checked and stop at
00:01:37
the end of the year but we will start with some european union support
00:01:41
uh in the framework of your stars project
00:01:47
uh i went to to point in the market will be in rehabilitation
00:01:50
clinics we will focus as well on ambulatory is we will have
00:01:55
our first turn over with a clinical with a partner in belgium
00:02:00
which is also the manufacturing partner that was starting to
00:02:02
then looks down please and it always will start in the
00:02:05
dog boundaries there is an experienced team around of engineers
00:02:10
and uh also already in the marketing because we want to perform to power will clinical trials
00:02:17
to really uh perform punk therapy with around thirty five patients
00:02:23
for the first round we need to acquire half a million of
00:02:26
swiss francs for serious prototype development and also market expiration
00:02:32
second round will be one point two millions to both the
00:02:36
market and also to develop the virtual reality software
00:02:41
thank you for listening and everything that you re you are high
00:02:51
it's a rich
00:02:55
i i i
00:02:59
there are some studies they're not from us we only have to twelve patients at the moment
00:03:03
but there are some therapies on the sitting ball which is quite promising they really have some good
00:03:09
training effect at the end where people were able to walk earlier off the stroke so
00:03:14
with the concept is given for the sitting board which costs without the swiss francs
00:03:19
i was will be a little bit the more expensive but it will
00:03:23
cost to less at the end because you can do independent therapy
00:03:27
thank you thank you very much i think the bees

Share this talk: 


Conference Program

elthera
Oct. 25, 2017 · 11:12 a.m.
257 views
SunRegen
Oct. 25, 2017 · 11:16 a.m.
329 views
GRATXRAY
Oct. 25, 2017 · 11:20 a.m.
272 views
certus diagnostics
Oct. 25, 2017 · 11:29 a.m.
224 views
Trackcath?
Oct. 25, 2017 · 11:32 a.m.
retinai
Oct. 25, 2017 · 11:36 a.m.
334 views
scailyte
Oct. 25, 2017 · 11:40 a.m.
241 views
Ophtho robotics
Oct. 25, 2017 · 11:45 a.m.
234 views
Dicronis
Oct. 25, 2017 · 11:49 a.m.
318 views
IDUN
Oct. 25, 2017 · 11:53 a.m.
198 views
steriLux
Oct. 25, 2017 · 11:56 a.m.
144 views
T-CHAIR
Oct. 25, 2017 · 12:01 p.m.
129 views
AESYRA
Oct. 25, 2017 · 12:04 p.m.
476 views
FlavorWiki
Oct. 25, 2017 · 12:09 p.m.
367 views
Algrano
Oct. 25, 2017 · 12:12 p.m.
498 views
BioSens
Oct. 25, 2017 · 12:17 p.m.
171 views
Farmerline
Oct. 25, 2017 · 12:21 p.m.
104 views